Every February 4th, World Cancer Day unites the world’s population in the fight against cancer. It aims to save millions of preventable deaths each year by raising awareness and education about the disease, pressing governments and individuals across the world to take action.
From 2016, it embarks on a three years campaign with the theme of “We Can. I Can.”
“We Can.”: It lays out how community can collectively do their part to reduce the global burden of cancer.
“I Can.”: It calls on individuals to take responsibility for reducing their own cancer risk and burden.
According to the Ministry of Health and Singapore Cancer Registry, cancer is the number 1 killer in Singapore. 1 in 3 Singaporeans dies of cancer, 17 people die from cancer every day and 37 people are diagnosed with cancer every day.
Cancer is widespread but due to the lack of awareness, it is treated as a taboo with cancer patients often being subjected to discrimination and stigma. It is also a misbelief that the onus solely lies on the patients but “We can. I can.” lists out what we can do in our capacity to help. Just as cancer affects everyone in different ways, all people have the power to take various actions to reduce the impact that cancer has on individuals, families and communities.
In CSI Singapore, we do our part to support World Cancer Day by providing high quality cancer research aimed at finding the causes and discovering novel therapeutic options to fight against cancer.
Highlights Of What We Do:
Unravelling the Underlying Cause of Cancer
Assistant Professor Sudhakar Jha and his team have discovered the functional role of TIP60 and novel interactions between EDD1 and TIP60 in viral-mediated cancer such as HPV-induced cervical cancer. This is the fourth most common cause of cancer and deaths from cancer in women. Understanding how these two proteins interact with the HPV E6 oncogene lay the ground for future development of therapeutic options for cervical cancer. This is a breakthrough as there is currently no specific treatment available at this moment for HPV-induced cancer.
Read more here: NUS finding may lead to new cervical cancer treatments
Discovering Novel Therapeutic Option
Prof Chng Wee Joo and his team found a new use for an old ineffective drug. Research has been conducted and it has been found to be effective in inhibiting the growth of colorectal cancer. This shows that PRIMA-1met drug could be used to treat colorectal cancer — the most common cancer in Singapore.
Read more here: NUS researchers find new promise in old cancer drug
How Can You Help?
YOU CAN make a difference! Support our research by making a donation to CSI Singapore today. Your gift to us will accelerate our abilities to continue this vital work. Big or small, contributions will be carefully invested in important areas such as clinical trials, research technologies, and graduate program to help shape the next generation of innovative cancer research.